Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  company  global  july prnewswire  july  market  new  plant market  prnewswire  research  therapeutics  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Sat, 22 Jul 2017 14:58:16 EDT

Last Build Date: Fri, 21 Jul 2017 16:31:00 EDT

 



Pharmaceutical Companies Need an Effective Global Branding Process for New Products to Ensure Success across Geographies and Affiliates

Fri, 21 Jul 2017 16:31:00 EDT

(image) CHAPEL HILL, N.C., July 21, 2017 /PRNewswire/ -- An effective global branding process has never been more important to a pharmaceutical company that has operations around the world. As pharma and biotech companies turn to other regions of the world to drive growth, it is important...



Media Files:
http://www.best-in-class.com




GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus

Fri, 21 Jul 2017 15:18:00 EDT

LONDON, July 21, 2017 /PRNewswire/ -- GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody-positive SLE who are receiving standard therapy....



Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility

Fri, 21 Jul 2017 15:14:00 EDT

(image) FREMONT, Calif., July 21, 2017 /PRNewswire/ -- Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and highly-skilled positions to the City of Fremont. The site was recently...



Media Files:
https://mma.prnewswire.com/media/537919/Boehringer_Ingelheim_Fremont_CA.jpg




United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017

Fri, 21 Jul 2017 12:30:00 EDT

(image) SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 21, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2017 financial results before the market opens on Thursday, July 27, 2017. United Therapeutics will...



Media Files:
http://www.unither.com




Las gotas oftálmicas de Cenegermin reciben la aprobación europea: el primer fármaco biotecnológico que resulta de la investigación de Dompé para el tratamiento de la queratitis neurotrófica entre moderada y grave se fabrica en Italia

Fri, 21 Jul 2017 11:00:00 EDT

Tras el desarrollo de cenegermin hay décadas de investigación italiana, procedente de los estudios de Rita Levi Montalcini, ganadora del Premio Nobel de Medicina por el descubrimiento del factor de crecimiento nervioso (NGF).      En 2015, el producto fue designado como un...



Congress Could Have Major Impact on Biotech Companies

Fri, 21 Jul 2017 10:48:00 EDT

LAS VEGAS, July 21, 2017 /PRNewswire/ -- Senate Republicans introduced a revised version of the health care repeal aiming to replace the Affordable Care Act earlier this month. Repealing the law was a top priority for Mr. Trump and Republicans in Congress, claiming the law has driven...



Genprex Files Registration Statement For Proposed Initial Public Offering

Fri, 21 Jul 2017 10:45:00 EDT

(image) AUSTIN, Texas, July 21, 2017 /PRNewswire/ -- Genprex, Inc., a clinical stage biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common...



Media Files:
https://mma.prnewswire.com/media/537989/genprex_Logo.jpg




AbbVie Receives CHMP Positive Opinion for HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis

Fri, 21 Jul 2017 09:36:00 EDT

(image) NORTH CHICAGO, Ill., July 21, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for HUMIRA® (adalimumab) for...



Media Files:
http://www.abbvie.com




Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM

Fri, 21 Jul 2017 09:30:00 EDT

(image) GAITHERSBURG, Md., July 21, 2017 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will host a conference call and webcast on Monday, July 24, 2017, at 4:30 p.m. ET.  Novavax anticipates receiving results and announcing topline data from its Phase 2 safety and immunogenicity...



Media Files:
http://novavax.com




Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer

Fri, 21 Jul 2017 09:28:00 EDT

(image) SAN DIEGO, July 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, announced that Julie Cooke is joining as Chief People Officer in September 2017 and will be a member of the Management...



Media Files:
http://www.neurocrine.com




Congress Could Have Major Impact on Biotech Companies

Fri, 21 Jul 2017 09:00:00 EDT

LAS VEGAS, July 21, 2017 /PRNewswire/ -- Senate Republicans introduced a revised version of the health care repeal aiming to replace the Affordable Care Act earlier this month. Repealing the law was a top priority for Mr. Trump and Republicans in Congress, claiming the law has driven...



Endo to Restructure Manufacturing Network

Fri, 21 Jul 2017 08:30:00 EDT

(image) DUBLIN, July 21, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that after completing a comprehensive review of its manufacturing network, the Company will be ceasing operations and closing its manufacturing and distribution facilities in Huntsville, Alabama....



Media Files:
http://www.endo.com




VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer

Fri, 21 Jul 2017 08:00:00 EDT

GAITHERSBURG, Md., July 21, 2017 /PRNewswire/ -- VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the appointment of Jacob Licht as Chief Operating Officer....



Breakfast Technical Briefing on Biotech Stocks -- Aurinia Pharma, Esperion Therapeutics, Paratek Pharma, and Verastem

Fri, 21 Jul 2017 06:10:00 EDT

NEW YORK, July 21, 2017 /PRNewswire/ -- If you want a Stock Review on AUPH, ESPR, PRTK, or VSTM then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Focus is on the Biotech industry, which broadly segments into the medical and...



New PhRMA resources chock full of biopharma industry facts

Fri, 21 Jul 2017 05:37:00 EDT

(image) WASHINGTON, July 21, 2017 /PRNewswire-USNewswire/ -- Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for 14 percent of total national health...



Media Files:
https://mma.prnewswire.com/media/537880/Pharmaceutical_Research_and_Manufacturers_of_America_bar_graph_Infographic.jpg




Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

Fri, 21 Jul 2017 01:00:00 EDT

(image) HACKENSACK, N.J. and PETACH TIKVA, Israel, July 21, 2017 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the California Institute for Regenerative Medicine (CIRM) has...



Media Files:
https://mma.prnewswire.com/media/150511/brainstorm_cell_therapeutics_inc_logo.jpg




Biogas Plant Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast 2016 - 2022

Thu, 20 Jul 2017 20:25:00 EDT

(image) NEW YORK, July 20, 2017 /PRNewswire/ -- Global Biogas Plant Market: OverviewThe global biogas plant market report by Transparency Market Research provides in-depth analysis of the biogas plant market globally. The report segments the market on the basis of feedstock type and...



Media Files:
http://www.reportlinker.com




Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompé Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy

Thu, 20 Jul 2017 19:38:00 EDT

(image) MILAN, July 20, 2017 /PRNewswire/ -- Behind the development of cenegermin are decades of Italian research, stemming from the studies of Rita Levi Montalcini, winner of the Nobel Prize in Medicine for the discovery of the nerve growth factor (NGF). In 2015, the product...



Media Files:
http://mma.prnewswire.com/media/531471/Dompe.jpg




Preimplantation Genetic Testing Market by Type, Technology, Products & Services, Application, End User - Forecast to 2022

Thu, 20 Jul 2017 18:16:00 EDT

(image) NEW YORK, July 20, 2017 /PRNewswire/ -- "Preimplantation genetic testing market projected to grow at a CAGR of 10.0%" The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4 million in 2017, at a CAGR of 10.0%. Growing...



Media Files:
http://www.reportlinker.com




FDA Accepts Biologics License Application for AMG 334 (Erenumab), an Important Regulatory Milestone for Novartis

Thu, 20 Jul 2017 16:38:00 EDT

EAST HANOVER, N.J., July 20, 2017 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334 (erenumab) for the prevention of migraine in patients experiencing four or more migraine...